Literature DB >> 27249030

Imaging in acute stroke.

Prasanna Eswaradass1, Ramana Appireddy1, James Evans1, Carol Tham1, Sadanand Dey1, Mohamed Najm1, Bijoy K Menon1,2,3,4.   

Abstract

INTRODUCTION: Stroke is the third leading cause of death and disability in Canada. In the hyperacute stroke setting, the treating physician must make a time critical decision on the treatment of each patient. Recent advances in imaging help the treating physician identify the subgroup of patients eligible for acute treatment of ischaemic stroke. AREAS COVERED: In this review we will discuss Non-Contrast Computed Tomography (NCCT), CT-Angiography (CTA), and CT-Perfusion (CTP) in assessment of patients with acute ischaemic stroke and intracerebral haemorrhage. Intravenous tPA was the only proven therapy for acute ischaemic stroke presenting within 4.5 hours, until the five recent trials proved the efficacy of EVT for acute ischaemic stroke with proximal arterial occlusion. Imaging played a major role in patient selection in all five trials. Expert commentary: The challenge of rapid clinical assessment, review of imaging and timely treatment will continue to be made easier as the development and understanding of imaging progresses.

Entities:  

Keywords:  CT; angiography; imaging; perfusion; stroke; thrombolysis

Mesh:

Year:  2016        PMID: 27249030     DOI: 10.1080/14779072.2016.1196134

Source DB:  PubMed          Journal:  Expert Rev Cardiovasc Ther        ISSN: 1477-9072


  3 in total

1.  Head and neck angiography at 70 kVp with a third-generation dual-source CT system in patients: comparison with 100 kVp.

Authors:  Yu Chen; Xiaobo Zhang; Huadan Xue; Yuanli Zhu; Yun Wang; Yumei Li; Zhuhua Zhang; Zhengyu Jin
Journal:  Neuroradiology       Date:  2017-08-24       Impact factor: 2.804

Review 2.  Role of Decompressive Craniectomy in Ischemic Stroke.

Authors:  Lars-Peder Pallesen; Kristian Barlinn; Volker Puetz
Journal:  Front Neurol       Date:  2019-01-09       Impact factor: 4.003

3.  NODDI highlights recovery mechanisms in white and gray matter in ischemic stroke following human stem cell treatment.

Authors:  F Andrew Bagdasarian; Xuegang Yuan; Jacob Athey; Bruce A Bunnell; Samuel C Grant
Journal:  Magn Reson Med       Date:  2021-08-06       Impact factor: 3.737

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.